Savior Lifetec Corporation (TPEX:4167)
18.40
+0.35 (1.94%)
Dec 31, 2025, 1:30 PM CST
Savior Lifetec Market Cap
Savior Lifetec has a market cap or net worth of 5.71 billion as of December 31, 2025. Its market cap has decreased by -12.64% in one year.
Market Cap
5.71B
Enterprise Value
4.32B
Revenue
1.16B
Ranking
n/a
PE Ratio
11.75
Stock Price
18.40
Market Cap Chart
Since December 21, 2012, Savior Lifetec's market cap has increased from 3.75B to 5.71B, an increase of 52.32%. That is a compound annual growth rate of 3.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 5.71B | -11.78% |
| Dec 31, 2024 | 6.47B | -9.13% |
| Dec 29, 2023 | 7.13B | -9.37% |
| Dec 30, 2022 | 7.86B | 29.94% |
| Dec 30, 2021 | 6.05B | -41.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.90B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 31.06B |